CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients ; volume:22 ; number:1 ; day:11 ; month:11 ; year:2020 ; pages:1-13 ; date:12.2020
Breast cancer research ; 22, Heft 1 (11.11.2020), 1-13, 12.2020
- Urheber
-
Kimbung, Siker
Inasu, Maria
Stålhammar, Tor
Nodin, Björn
Elebro, Karin
Tryggvadottir, Helga
Ygland Rödström, Maria
Jirström, Karin
Isaksson, Karolin
Jernström, Helena
Borgquist, Signe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-020-01347-x
- URN
-
urn:nbn:de:101:1-2020122219084530672949
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kimbung, Siker
- Inasu, Maria
- Stålhammar, Tor
- Nodin, Björn
- Elebro, Karin
- Tryggvadottir, Helga
- Ygland Rödström, Maria
- Jirström, Karin
- Isaksson, Karolin
- Jernström, Helena
- Borgquist, Signe
- SpringerLink (Online service)
Ähnliche Objekte (12)
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer